Conclusions
Our results showed that the therapeutic recommendations were not strictly followed among T1DM patients in France. Better adherence to the T1DM guidelines would lead to cost savings in the French healthcare system and improved patient outcomes.
Results
A cohort of 605 T1DM patients (43% male) was analyzed. Mean age at inclusion in the cohort visit was 58 years, HbA1c was 7.8%, SBP was 132 mmHg, and BMI was 28 kg/m 2 . Smokers represented 23% of the cohort. In contrast, the HAS recommends an HbA1c lower than 7.5%, SBP lower than 130 mmHg, BMI of less than 25 kg/m 2 and smoking abstinence is recommended.
Results from economic modeling using the CDM suggest that for prevalent T1DM patients in France, potential savings for the health care system associated with meeting the therapeutic guidelines would be on average of 1,659 EUR per patient from a lifetime perspective. Most of the savings would come from the prevention of renal complications. Any new complication would be delayed by 2.4 months on average.
Assuming that there are currently 160,000 T1DM patients in France (11) and that they would all meet the HAS recommendations, this could translate in 265 million EUR savings over their lifetime.
Methods
The IMS CORE Diabetes Model (CDM) is a health economic model based on 17 inter-dependent sub-models that simulate micro-and macrovascular complications associated with diabetes (2).
Physiological parameter inputs such as HbA1c, blood lipids, body mass index (BMI), and systolic blood pressure (SBP) were taken from real-life data and compared with guidelines from the "Haute Autorité de Santé". 
Objectives
The aim of this study was to investigate the burden of type 1 diabetes mellitus (T1DM) in France associated with non-adherence to clinical guidelines. The IMS CORE Diabetes Model (CDM) was applied using clinical data from the IMS Lifelink Diabetes Cohort in France.
Introduction
Type 1 diabetes mellitus (T1DM) represents about 10% of the diabetes case in France and half of them are diagnosed before their 20th birthday. The French prevalence is 13.5 cases per 100,000 children of less than 15 years of age. For unknown reasons, the prevalence of T1DM is constantly increasing since about two decades and there is a trend towards earlier incidence. (1) 
